Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03157089
Title Testing Afatinib in Combination With Pembrolizumab in Patients With Squamous Cell Carcinoma of the Lung (LUX-Lung IO)
Acronym LUX-Lung-IO
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Boehringer Ingelheim
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | TUR | FRA | ESP

Facility Status City State Zip Country Details
Baptist Health Medical Group Lexington Kentucky 40503 United States Details
HOP Côte de Nacre Caen 14033 France Details
HOP Le Mans Le Mans 72037 France Details
HOP Nord Marseille 13015 France Details
HOP Nord Laënnec Nantes 44093 France Details
Severance Hospital Seoul 03722 Korea, Republic of Details
Asan Medical Center Seoul 05505 Korea, Republic of Details
Hospital Vall d'Hebron Barcelona 08035 Spain Details
Complejo Hospitalario Universitario Insular - Materno Infantil Las Palmas de Gran Canaria 35016 Spain Details
Hospital Universitario 12 de Octubre Madrid 28041 Spain Details
Hospital Clínico Universitario Lozano Blesa Zaragoza 50009 Spain Details
Hacettepe Universitesi Tip Fakultesi, Onkoloji ABD Ankara 06230 Turkey Details
Istanbul Universitesi Cerrahpasa Tip Fakultesi Istanbul 34098 Turkey Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field